低位迷你胸骨切开术:治疗所有瓣膜病的入路?
这项回顾性研究纳入2017年1月至2023年3月在Pitié-Salpêtrière医院接受低位迷你胸骨切开术的633例成人心脏手术患者,评估全因死亡、术后并发症和超声心动图结果。结果显示该入路可安全用于主动脉瓣、二尖瓣、三尖瓣及合并手术和其他心内手术,住院生存率96%-99.1%,并发症率较低。
要点
- 低位迷你胸骨切开术可用于主动脉瓣、二尖瓣、三尖瓣及合并心内手术。
- 633例患者住院生存率96%-99.1%,仅1例需再次固定胸骨。
- 术后纵隔炎2.1%,永久性卒中1.7%,新起搏器植入7.5%,输血25%。
核心结论
- 低位迷你胸骨切开术是治疗所有瓣膜病(单独或合并)及其他心内疾病的安全入路,与低发病率 and 死亡率相关。
研究设计与样本
- 回顾性研究,纳入2017年1月至2023年3月在Pitié-Salpêtrière医院接受低位迷你胸骨切开术的633例连续成人患者。
主要发现
- 338例接受主动脉瓣手术(AVS)伴或不伴三尖瓣成形术(TA),254例接受二尖瓣手术(MVS)伴或不伴TA,25例接受AVS和MVS伴或不伴TA,38例接受其他心内手术。
- 住院生存率:AVS组99.1%,MVS伴或不伴TA组98.1%,AVS和MVS伴或不伴TA组96%,其他心内手术组97.4%。
- 整个队列仅1例需再次固定胸骨,12例(2.1%)发生纵隔炎,162例(25%)接受输血,11例(1.7%)发生永久性卒中,49例(7.5%)接受新起搏器植入。
临床怎么用
- 对于适合的瓣膜病及心内手术患者,可考虑采用低位迷你胸骨切开术,以期获得良好的心脏四腔显露并降低并发症风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lower ministernotomy offers the advantage of providing excellent visualization of the 4 cardiac cavities, thus allowing surgical treatment of the aortic, mitral, and tricuspid valves as well as any intracavitary procedure. Information on technical issues, as well as safety and echocardiographic results of this approach, are sparse. The aim of this retrospective study was to describe outcomes of lower ministernotomy to treat valvulopathies and for other intracardiac surgical procedures. METHODS: All consecutive patients aged more than 18 years who underwent cardiac surgery by ministernotomy between January 2017 and March 2023 in our institution (Pitié-Salpêtrière Hospital, Sorbonne University, Paris, France) were included in this retrospective study. Main outcome variables were all-cause mortality, postoperative complications, and echocardiographic results. RESULTS: During the 6-year study period, 633 patients were treated through a lower ministernotomy. Among them, 338 patients had aortic valve surgery (AVS) with or without tricuspid annuloplasty (TA), 254 had mitral valve surgery (MVS) with or without TA, 25 had AVS and MVS with or without TA, and 38 had other types of intracardiac surgery. Hospital survival was 99.1% in the AVS group, 98.1% in the MVS with or without TA group, 96% in the AVS and MVS with or without TA group, and 97.4% in the other intracardiac surgery group. Only 1 patient required repeat osteosynthesis in the entire cohort, and 12 (2.1%) patients had mediastinitis. A total of 162 (25%) patients received transfusions, 11 patients (1.7%) had permanent strokes, and 49 (7.5%) underwent new pacemaker implantation. CONCLUSIONS: Lower ministernotomy is a safe approach for treating all valvulopathies, separately or concomitantly, and other intracardiac diseases, and it is associated with a low rate of morbidity and mortality.
引用
- Danial P, Frering A, Bouhdadi H, et al. Lower Ministernotomy: An Approach for Treating All Valvulopathies? Ann Thorac Surg. 2024. PMID: 39732414. doi:10.1016/j.athoracsur.2024.12.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。